At Atomic AI, we are harnessing the cutting-edge fusion of machine learning and structural biology to unlock the next generation of RNA-centric medicines, from RNA-targeted small molecules to RNA-based therapeutics.
Our ATOM-1 foundation model allows for the world’s most precise predictions of the structure and function of RNA and is unlocking a range of new therapeutic possibilities.

Our proprietary R&D platform leverages ATOM-1, a state-of-the-art RNA foundation model, integrated into a virtuous cycle with purpose-built, in-house wet-lab assays, to create the next generation of RNA-centric medicines.